At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 20 enrolled
Drug / intervention
Topicort Topical Spraydrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open-Label, Study Evaluating Topicort® Topical Spray 0.25% (Desoximetasone) in Patients With Scalp Psoriasis
Psoriasis Treatment Center of Central New Jersey·interventional·Posted Dec 7, 2016·Updated Apr 9, 2024
In Brief
A Phase 4 clinical trial evaluating Topicort Topical Spray for Psoriasis. Completed, enrolled 20 participants across 1 site.
Detailed Summary
A single center, study of 20 subjects to assess 4 weeks of therapy with Topicort® twice daily BID and 12 weeks twice daily on 2 consecutive days to patients with scalp psoriasis
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPsoriasis
CountriesUnited States
CollaboratorsSun Pharmaceutical Industries, Inc.
Timeline
Phase 4CompletedFinished
2017201820192020202120222023202420252026
Enrollment StartSep 2016
First PostedDec 2016
Primary CompletionJan 2017
TodayJul 2026
First PostedDec 7, 2016
Enrollment StartSep 1, 2016
Primary CompletionJan 27, 2017
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 9.6 years ago
Interventions
Topicort Topical Spraydrug